
BNP Paribas Easy (BLUE) | Financial Analysis & Statements
BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF | Mid-cap | Healthcare
BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF | Mid-cap | Healthcare
Financial Overview
Latest Annual: 2019Income Metrics
Revenue
26.4M
Gross Profit
-7.2M
-27.22%
Operating Income
-41.4M
-157.01%
Net Income
-42.9M
-162.49%
Balance Sheet Metrics
Total Assets
185.7M
Total Liabilities
141.2M
Shareholders Equity
44.5M
Debt to Equity
3.18
Cash Flow Metrics
Operating Cash Flow
-47.4M
Free Cash Flow
-42.7M
Revenue & Profitability Trend
BNP Paribas Easy Income Statement From 2015 to 2019
Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|
Revenue | 26.4M | 38.2M | 80.7M | 109.3M | 121.9M |
Cost of Goods Sold | 33.6M | 34.6M | 61.3M | 69.5M | 81.3M |
Gross Profit | -7.2M | 3.6M | 19.4M | 39.9M | 40.5M |
Operating Expenses | -10.2M | -9.5M | -9.0M | -8.4M | -7.7M |
Operating Income | -41.4M | -30.4M | -19.7M | -299.0K | 3.8M |
Pre-tax Income | -42.3M | -32.7M | -21.2M | 1.3M | 508.0K |
Income Tax | 568.0K | 690.0K | -2.0M | 1.3M | 488.0K |
Net Income | -42.9M | -33.4M | -19.2M | -80.0K | 20.0K |
EPS (Diluted) | - | -€1.14 | -€0.67 | €0.00 | €0.00 |
Income Statement Trend
BNP Paribas Easy Balance Sheet From 2015 to 2019
Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 34.7M | 30.0M | 35.9M | 54.1M | 62.9M |
Non-Current Assets | 151.0M | 145.1M | 149.3M | 157.0M | 133.0M |
Total Assets | 185.7M | 175.1M | 185.1M | 211.2M | 195.9M |
Liabilities | |||||
Current Liabilities | 82.2M | 41.9M | 21.4M | 19.9M | 22.5M |
Non-Current Liabilities | 59.1M | 45.5M | 45.9M | 52.9M | 37.7M |
Total Liabilities | 141.2M | 87.4M | 67.3M | 72.8M | 60.2M |
Equity | |||||
Total Shareholders Equity | 44.5M | 87.7M | 117.8M | 138.4M | 135.7M |
Balance Sheet Composition
BNP Paribas Easy Cash Flow Statement From 2015 to 2019
Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -42.9M | -33.4M | -19.2M | -80.0K | 20.0K |
Operating Cash Flow | -47.4M | -26.2M | -8.1M | 5.5M | -2.0M |
Investing Activities | |||||
Capital Expenditures | -8.9M | -6.0M | -12.0M | -15.6M | -15.1M |
Investing Cash Flow | -8.8M | -5.5M | -11.9M | -23.4M | -15.2M |
Financing Activities | |||||
Dividends Paid | - | - | - | - | - |
Financing Cash Flow | 1.3M | 1.3M | - | - | 59.0K |
Free Cash Flow | -42.7M | -19.0M | -9.0M | 1.7M | 2.0M |
Cash Flow Trend
BNP Paribas Easy Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.91
Price to Sales
17.32
Profitability Ratios
Profit Margin
-27.22%
Operating Margin
-156.86%
Return on Equity
-96.39%
Return on Assets
-23.08%
Financial Health
Current Ratio
0.42
Debt to Equity
2.22
Per Share Data
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
blue | 456.7M | 15.91 | - | -96.39% | -27.22% | 2.22 |
Medincell S.A | 565.5M | -18.81 | - | 61.33% | -66.50% | -1.44 |
Valneva SE | 409.5M | 70.64 | 2.11 | -44.11% | -43.21% | 120.48 |
Abivax SA | 331.7M | -1.96 | -52.78 | -196.12% | 0.00% | -16.16 |
Inventiva S.A | 379.0M | -0.88 | -0.99 | 172.73% | 0.00% | -1.70 |
Viridian | 415.4M | 50.43 | 0.40 | 0.93% | 2.05% | 103.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.